These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors. Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231 [TBL] [Abstract][Full Text] [Related]
18. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase. Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122 [TBL] [Abstract][Full Text] [Related]
19. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives. Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055 [TBL] [Abstract][Full Text] [Related]
20. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate. McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]